CARY, N.C. (AP) — CARY, N.C. (AP) — Heron Therapeutics Inc. (HRTX) on Friday reported a loss of $2.4 million in its second quarter.
The Cary, North Carolina-based company said it had a loss of 2 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.
The pharmaceutical company posted revenue of $37.2 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $37.9 million.
Heron Therapeutics expects full-year revenue in the range of $153 million to $163 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX
/A%20Palantir%20sign%20displayed%20on%20an%20office%20building%20by%20Poetra_RH%20via%20Shutterstock.jpg)
/Chipset%20held%20over%20rush%20hour%20traffic%20by%20Jae%20Young%20Ju%20via%20iStock.jpg)
/Meta%20by%20creativeneko%20via%20Shutterstock.jpg)
/Tesla%20charging%20station%20black%20background%20by%20Blomst%20via%20Pixabay.jpg)